Ignite Creation Date:
2024-05-06 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05161195
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2021-12-03
Brief Title:
Roll-over Study to Allow Continued Access to Ribociclib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2030-02-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-26
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-03
First Submit QC Date:
December 3 2021
Study First Post Date:
2021-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-11
Last Update Post Date:
2024-06-13
Last Update Post Date Type:
ACTUAL